A database of human genes and a gene network involved in response to tick-borne encephalitis virus infection

BMC Evolutionary Biology

Volumn 17, Issue , 2017, Pages

  Ignatieva, Elena V ^a,b   Igoshin, Alexander V ^a   Yudin, Nikolay S ^a,b  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Candidate genes; Database; Flavivirus; Network; PPIs; TBEV; Tick borne encephalitis

Indexed keywords

DATABASE; GENE; GENETIC ANALYSIS; INFECTIOUS DISEASE; NEUROLOGY; PROTEIN; RISK FACTOR; RNA; TICK; VIRAL DISEASE; VIRUS;

FLAVIVIRUS; IXODIDA; RNA VIRUSES; TICK-BORNE ENCEPHALITIS VIRUS;

VIRUS RNA;

ANIMAL; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; INTERNET; PHYSIOLOGY; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS VIRUS; VIROLOGY;

ANIMALS; DATABASES, GENETIC; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; GENE REGULATORY NETWORKS; HUMANS; INTERNET; RNA, VIRAL;

EID: 85039758438     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/s12862-017-1107-8     Document Type: Article

References (97)

1. Kaiser R. Tick-borne encephalitis: clinical findings and prognosis in adults. Wien Med Wochenschr. 2012;162(11-12):239-43. doi: 10.1007/s10354-012-0105-0.
2. Süss J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick Borne Dis. 2011;2(1):2-15. doi: 10.1016/j.ttbdis.2010.10.007.
3. Růžek D, Dobler G, Donoso Mantke O. Tick-borne encephalitis: pathogenesis and clinical implications. Travel Med Infect Dis. 2010;8(4):223-32. doi: 10.1016/j.tmaid.2010.06.004.
4. Kunze U. The international scientific working group on tick-borne encephalitis (ISW TBE): review of 17 years of activity and commitment. Ticks Tick Borne Dis. 2016;7(3):399-404. doi: 10.1016/j.ttbdis.2015.12.018.
5. Robertson SJ, Mitzel DN, Taylor RT, Best SM, Bloom ME. Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures. Immunol Res. 2009;43(1-3):172-86. doi: 10.1007/s12026-008-8065-6.
6. Weststrate AC, Knapen D, Laverman GD, Schot B, Prick JJ, Spit SA, Reimerink J, Rockx B, Geeraedts F. Increasing evidence of tick-borne encephalitis (TBE) virus transmission, the Netherlands, June 2016. Euro Surveill. 2017;22(11):30482. doi: 10.2807/1560-7917.ES.2017.22.11.30482.
7. Dörrbecker B, Dobler G, Spiegel M, Hufert FT. Tick-borne encephalitis virus and the immune response of the mammalian host. Travel Med Infect Dis. 2010;8(4):213-22. doi: 10.1016/j.tmaid.2010.05.010.
8. Brinton MA, Perelygin AA. Genetic resistance to flaviviruses. Adv Virus Res. 2003;60:43-85.
9. Vannberg FO, Chapman SJ, Hill AV. Human genetic susceptibility to intracellular pathogens. Immunol Rev. 2011;240(1):105-16. doi: 10.1111/j.1600-065X.2010.00996.x.
10. Loeb M. Genetic susceptibility to West Nile virus and dengue. Public Health Genomics. 2013;16(1-2):4-8. doi: 10.1159/000345934.
11. Eslam M, George J. Genome-wide association studies and hepatitis C: harvesting the benefits of the genomic revolution. Semin Liver Dis. 2015;35(4):402-20. doi: 10.1055/s-0035-1567830.
12. Barkhash AV, Perelygin AA, Babenko VN, Myasnikova NG, Pilipenko PI, Romaschenko AG, Voevoda MI, Brinton MA. Variability in the 2′-5′-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J Infect Dis. 2010;202:1813-8.
13. Barkhash AV, Perelygin AA, Babenko VN, Brinton MA, Voevoda MI. Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis. Antivir Res. 2012;93:64-8.
14. Barkhash AV, Voevoda MI, Romaschenko AG. Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population. Antivir Res. 2013;99:136-8.
15. Barkhash AV, Babenko VN, Voevoda MI, Romaschenko AG. Association of IL28B and IL10 gene polymorphism with predisposition to tick-borne encephalitis in a Russian population. Ticks Tick-Borne Dis. 2016;7(5):808-12.
16. Kindberg E, Mickiene A, Ax C, Akerlind B, Vene S, Lindquist L, Lundkvist A, Svensson L. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis. 2008;197:266-9.
17. Kindberg E, Vene S, Mickiene A, Lundkvist A, Lindquist L, Svensson L. A functional toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. J Infect Dis. 2011;203:523-8.
18. Mickienė A, Pakalnienė J, Nordgren J, Carlsson B, Hagbom M, Svensson L, Lindquist L. Polymorphisms in chemokine receptor 5 and toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population. PLoS One. 2014;9(9):e106798. doi: 10.1371/journal.pone.0106798.
19. Turtle L, Griffiths MJ, Solomon T. Encephalitis caused by flaviviruses. QJM. 2012;105(3):219-23. doi: 10.1093/qjmed/hcs013.
20. Blake LE, Garcia-Blanco MA. Human genetic variation and yellow fever mortality during 19th century U.S. epidemics. MBio. 2014;5(3):e01253-14. doi: 10.1128/mBio.01253-14.
21. Bogovic P, Strle F. Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases. 2015;3(5):430-41. doi: 10.12998/wjcc.v3.i5.430.
22. Yudin NS, Barkhash AV, Maksimov VN, Ignatieva EV, Romaschenko AG. Human genetic predisposition to diseases caused by viruses from Flaviviridae family. Mol Biol (Mosk). 2018;52(2) (in press).
23. Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antivir Res. 2003;57(1-2):129-46.
24. Gritsun TS, Nuttall PA, Gould EA. Tick-borne flaviviruses. Adv Virus Res. 2003;61:317-71.
25. Mandl CW. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. Virus Res. 2005;111(2):161-74.
26. Best SM. The many faces of the Flavivirus NS5 protein in antagonism of type I interferon signaling. J Virol. 2017;91(3):e01970-16. doi: 10.1128/JVI.01970-16.
27. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, Xavier RJ, Agaisse H, Fikrig E. RNA interference screen for human genes associated with West Nile virus infection. Nature. 2008;455(7210):242-5. doi: 10.1038/nature07207.
28. Mlera L, Lam J, Offerdahl DK, Martens C, Sturdevant D, Turner CV, Porcella SF, Bloom ME. Transcriptome analysis reveals a signature profile for tick-borne Flavivirus persistence in HEK 293T cells. MBio. 2016;7(3):e00314-6. doi: 10.1128/mBio.00314-16.
29. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, Dunstan SJ, Wills B, Farrar J, Van Tram T, Gan TT, Binh NT, Tri le T, Lien le B, Tuan NM, Tham NT, Lanh MN, Nguyet NM, Hieu NT, Van N Vinh Chau N, Thuy TT, Tan DE, Sakuntabhai A, Teo YY, Hibberd ML, Simmons CP. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet. 2011;43(11):1139-41. doi: 10.1038/ng.960.
30. Le Breton M, Meyniel-Schicklin L, Deloire A, Coutard B, Canard B, de Lamballerie X, Andre P, Rabourdin-Combe C, Lotteau V, Davoust N. Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen. BMC Microbiol. 2011;11:234. doi: 10.1186/1471-2180-11-234.
31. Neal JW. Flaviviruses are neurotropic, but how do they invade the CNS? J Inf Secur. 2014;69(3):203-15. doi: 10.1016/j.jinf.2014.05.010.
32. Ramage H, Cherry S. Virus-host interactions: from unbiased genetic screens to function. Annu Rev Virol. 2015;2(1):497-524. doi: 10.1146/annurev-virology-100114-055238.
33. Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology. 2006;344(1):119-30.
34. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol. 2008;89(Pt 1):1-47.
35. Wang BX, Fish EN. The yin and yang of viruses and interferons. Trends Immunol. 2012;33(4):190-7. doi: 10.1016/j.it.2012.01.004.
36. Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362-8. doi: 10.1093/nar/gkw937.
37. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431-2.
38. Protopopova EV, Konavalova SN, Loktev VB. Isolation of a cellular receptor for tick-borne encephalitis virus using anti-idiotypic antibodies. Vopr Virusol. 1997;42(6):264-8. [Article in Russian]
39. Albornoz A, Carletti T, Corazza G, Marcello A. The stress granule component TIA-1 binds tick-borne encephalitis virus RNA and is recruited to perinuclear sites of viral replication to inhibit viral translation. J Virol. 2014;88(12):6611-22. doi: 10.1128/JVI.03736-13.
40. Dillmann C, Ringel C, Ringleb J, Mora J, Olesch C, Fink AF, Roberts E, Brüne B, Weigert A. S1PR4 signaling attenuates ILT 7 internalization to limit IFN-α production by human Plasmacytoid Dendritic cells. J Immunol. 2016;196(4):1579-90. doi: 10.4049/jimmunol.1403168.
41. Ignatieva EV, Levitsky VG, Yudin NS, Moshkin MP, Kolchanov NA. Genetic basis of olfactory cognition: extremely high level of DNA sequence polymorphism in promoter regions of the human olfactory receptor genes revealed using the 1000 genomes project dataset. Front Psychol. 2014;5:247. doi: 10.3389/fpsyg.2014.00247.
42. Ignatieva EV, Levitsky VG, Kolchanov NA. Human genes encoding transcription factors and chromatin-modifying proteins have low levels of promoter polymorphism: a study of 1000 genomes project data. Int J Genomics. 2015;2015:260159. doi: 10.1155/2015/260159.
43. Ignatieva EV, Podkolodnaya OA, Orlov YL, Vasiliev GV, Kolchanov NA. Regulatory genomics: integrated experimental and computer approaches. Genetika. 2015;51(4):409-29. [Article in Russian]
44. Levitsky VG, Oshchepkov DY, Klimova NV, Ignatieva EV, Vasiliev GV, Merkulov VM, Merkulova TI. Hidden heterogeneity of transcription factor binding sites: a case study of SF-1. Comput Biol Chem. 2016;64:19-32. doi: 10.1016/j.compbiolchem.2016.04.008.
45. Aitnazarov RB, Ignatieva EV, Bazarova NE, Levitsky VG, Knyazev SP, Gon Y, Yudin NS. Estimation of the role of single nucleotide polymorphism in Lymphotoxin Beta gene during pig domestication based on the Bioinformatic and experimental approaches. Rus J Genet Appl Res. 2016;6(8):816-24.
46. Grygorczuk S, Parczewski M, Moniuszko A, Świerzbińska R, Kondrusik M, Zajkowska J, Czupryna P, Dunaj J, Boroń-Kaczmarska A, Pancewicz S. Increased concentration of interferon lambda-3, interferon beta and interleukin-10 in the cerebrospinal fluid of patients with tick-borne encephalitis. Cytokine. 2015;71(2):125-31. doi: 10.1016/j.cyto.2014.10.001.
47. Wigerius M, Melik W, Elväng A, Johansson M. Rac1 and scribble are targets for the arrest of neurite outgrowth by TBE virus NS5. Mol Cell Neurosci. 2010;44(3):260-71. doi: 10.1016/j.mcn.2010.03.012.
48. Upadhyay AS, Vonderstein K, Pichlmair A, Stehling O, Bennett KL, Dobler G, Guo JT, Superti-Furga G, Lill R, Överby AK, Weber F. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell Microbiol. 2014;16(6):834-48. doi: 10.1111/cmi.12241.
49. Yu C, Achazi K, Niedrig M. Tick-borne encephalitis virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor 6 (ATF6) pathways of unfolded protein response. Virus Res. 2013;178(2):471-7. doi: 10.1016/j.virusres.2013.10.012.
50. Lubick KJ, Robertson SJ, McNally KL, Freedman BA, Rasmussen AL, Taylor RT, Walts AD, Tsuruda S, Sakai M, Ishizuka M, Boer EF, Foster EC, Chiramel AI, Addison CB, Green R, Kastner DL, Katze MG, Holland SM, Forlino A, Freeman AF, Boehm M, Yoshii K, Best SM. Flavivirus antagonism of type I interferon signaling reveals Prolidase as a regulator of IFNAR1 surface expression. Cell Host Microbe. 2015;18(1):61-74. doi: 10.1016/j.chom.2015.06.007.
51. Kurhade C, Zegenhagen L, Weber E, Nair S, Michaelsen-Preusse K, Spanier J, Gekara NO, Kröger A, Överby AK. Type I interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1. J Neuroinflammation. 2016;13:22. doi: 10.1186/s12974-016-0487-9.
52. Tun MM, Aoki K, Senba M, Buerano CC, Shirai K, Suzuki R, Morita K, Hayasaka D. Protective role of TNF-α, IL-10 and IL-2 in mice infected with the Oshima strain of tick-borne encephalitis virus. Sci Rep. 2014;4:5344. doi: 10.1038/srep05344.
53. Růžek D, Salát J, Singh SK, Kopecký J. Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells. PLoS One. 2011;6(5):e20472. doi: 10.1371/journal.pone.0020472.
54. Barkhash AV, Yurchenko AA, Yudin NS, Ignatieva EV, Kozlova IV, Borishchuk IA, Pozdnyakova LL, Voevoda MI, Romaschenko AG. Matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease. Tick Tick Borne Dis. 2018;9. In press.
55. Carletti T, Zakaria MK, Marcello A. The host cell response to tick-borne encephalitis virus. Biochem Biophys Res Commun. 2017;492(4):533-40. doi: 10.1016/j.bbrc.2017.02.006.
56. Guirimand T, Delmotte S, Navratil V. VirHostNet 2.0: surfing on the web of virus/host molecular interactions data. Nucleic Acids Res. 2015;43(Database issue):D583-7. doi: 10.1093/nar/gku1121.
57. Taylor KE, Mossman KL. Recent advances in understanding viral evasion of type I interferon. Immunology. 2013;138(3):190-7. doi: 10.1111/imm.12038.
58. Lindqvist R, Mundt F, Gilthorpe JD, Wölfel S, Gekara NO, Kröger A, Överby AK. Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects. J Neuroinflammation. 2016;13(1):277.
59. Majoros A, Platanitis E, Kernbauer-Hölzl E, Rosebrock F, Müller M, Decker T. Canonical and non-canonical aspects of JAK-STAT signaling: lessons from Interferons for cytokine responses. Front Immunol. 2017;8:29. doi: 10.3389/fimmu.2017.00029.
60. Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, Parmentier M. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood. 1999;94(6):1899-905.
61. Xiao X, Kinter A, Broder CC, Dimitrov DS. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. Exp Mol Pathol. 2000;68(3):133-8.
62. Palus M, Bílý T, Elsterová J, Langhansová H, Salát J, Vancová M, Růžek D. Infection and injury of human astrocytes by tick-borne encephalitis virus. J Gen Virol. 2014;95(Pt 11):2411-26. doi: 10.1099/vir.0.068411-0.
63. Palus M, Vojtíšková J, Salát J, Kopecký J, Grubhoffer L, Lipoldová M, Demant P, Růžek D. Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system. J Neuroinflammation. 2013;10:77. doi: 10.1186/1742-2094-10-77.
64. Tigabu B, Juelich T, Holbrook MR. Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models. Virology. 2010;408(1):57-63. doi: 10.1016/j.virol.2010.08.021.
65. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med. 2005;202:1087-98.
66. Regner M, Lobigs M. The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis. PLoS One. 2012;7:e44834.
67. Merzeniuk ZA, Churliaev IA, Nikiforova NV, Kuksinskiǐ VA, Lykova OF, Konysheva TV. The possible role of alpha 2-macroglobulin in regulating the immune components of the brain in tick-borne encephalitis. Zh Mikrobiol Epidemiol Immunobiol. 2000;3:76-8. [Article in Russian]
68. Havugimana PC, Hart GT, Nepusz T, Yang H, Turinsky AL, Li Z, Wang PI, Boutz DR, Fong V, Phanse S, Babu M, Craig SA, Hu P, Wan C, Vlasblom J, Dar VU, Bezginov A, Clark GW, Wu GC, Wodak SJ, Tillier ER, Paccanaro A, Marcotte EM, Emili A. A census of human soluble protein complexes. Cell. 2012;150(5):1068-81. doi: 10.1016/j.cell.2012.08.011.
69. Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, Parsons R, Zhao K, Wang W. PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev. 2005;19(14):1662-7.
70. Lehrer AT, Holbrook MR. Tick-borne encephalitis vaccines. J Bioterror Biodef. 2011;2011(Suppl 1):3.
71. Tonteri E, Kipar A, Voutilainen L, Vene S, Vaheri A, Vapalahti O, Lundkvist Å. The three subtypes of tick-borne encephalitis virus induce encephalitis in a natural host, the bank vole (Myodes glareolus). PLoS One. 2013;8(12):e81214. doi: 10.1371/journal.pone.0081214.
72. Pogodina VV, Bochkova NG, Karan' LS, Frolova MP, Trukhina AG, Malenko GV, Levina LS, Platonov AE. Comparative analysis of virulence of the Siberian and far-east subtypes of the tick-born encephalitis virus. Vopr Virusol. 2004;49(6):24-30. [Article in Russian]
73. Gäumann R, Růžek D, Mühlemann K, Strasser M, Beuret CM. Phylogenetic and virulence analysis of tick-borne encephalitis virus field isolates from Switzerland. J Med Virol. 2011;83(5):853-63. doi: 10.1002/jmv.21993.
74. Asghar N, Lee YP, Nilsson E, Lindqvist R, Melik W, Kröger A, Överby AK, Johansson M. The role of the poly(a) tract in the replication and virulence of tick-borne encephalitis virus. Sci Rep. 2016;6:39265. doi: 10.1038/srep39265.
75. Belikov SI, Kondratov IG, Potapova UV, Leonova GN. The relationship between the structure of the tick-borne encephalitis virus strains and their pathogenic properties. PLoS One. 2014;9(4):e94946. doi: 10.1371/journal.pone.0094946.
76. Sakai M, Yoshii K, Sunden Y, Yokozawa K, Hirano M, Kariwa H. Variable region of the 3' UTR is a critical virulence factor in the far-eastern subtype of tick-borne encephalitis virus in a mouse model. J Gen Virol. 2014;95(Pt 4):823-35. doi: 10.1099/vir.0.060046-0.
77. Sakai M, Muto M, Hirano M, Kariwa H, Yoshii K. Virulence of tick-borne encephalitis virus is associated with intact conformational viral RNA structures in the variable region of the 3'-UTR. Virus Res. 2015;203:36-40. doi: 10.1016/j.virusres.2015.03.006.
78. Leonova GN, Belikov SI, Kondratov IG, Takashima I. Comprehensive assessment of the genetics and virulence of tick-borne encephalitis virus strains isolated from patients with inapparent and clinical forms of the infection in the Russian far east. Virology. 2013;443(1):89-98. doi: 10.1016/j.virol.2013.04.029.
79. Luat le X, Tun MM, Buerano CC, Aoki K, Morita K, Hayasaka D. Pathologic potential of variant clones of the oshima strain of far-eastern subtype tick-borne encephalitis virus. Trop Med Health. 2014;42(1):15-23. doi: 10.2149/tmh.2013-27.
80. Krylova NV, Smolina TP, Leonova GN. Molecular mechanisms of interaction between human immune cells and far eastern tick-borne encephalitis virus strains. Immunol. 2015;28(5):272-81. doi: 10.1089/vim.2014.0083.
81. Motuzova OV, Akhmatova EA, Khomenkov VG, Akhmatova NK, Lebedinskaya OV, Karganova GG. Experimental infection caused by two variants of one tick-borne encephalitis virus strain: similar virulence, but different influence on lymphocyte subpopulation structure. Front. Immunol. 2015. Conference Abstract: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología. doi: 10.3389/conf.fimmu.2015.05.00184.
82. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001;2(12):967-77.
83. Hill AV. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet. 2006;40:469-86.
84. Newport MJ, Finan C. Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics. 2011;10(2):98-107. doi: 10.1093/bfgp/elq037.
85. Chapman SJ, Hill AV. Human genetic susceptibility to infectious disease. Nat Rev Genet. 2012;13(3):175-88. doi: 10.1038/nrg3114.
86. Ellencrona K, Syed A, Johansson M. Flavivirus NS5 associates with host-cell proteins zonula occludens-1 (ZO-1) and regulating synaptic membrane exocytosis-2 (RIMS2) via an internal PDZ binding mechanism. Biol Chem. 2009;390(4):319-23. doi: 10.1515/BC.2009.041.
87. Zajkowska JM, Izycka A, Jabłońska E, Hermanowska-Szpakowicz T, Kondrusik M, Pancewicz S, Grygorczuk S, Swierzbińska R. Serum and cerebrospinal concentrations of sICAM-1 sICAM-2, sICAM-3 in neuroborrellosis and tick borne encephalitis - preliminary report. Pol Merkur Lekarski. 2005;19(110):152-7. [Article in Polish]
88. Palus M, Zampachová E, Elsterová J, Růžek D. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis. J Inf Secur. 2014;68(2):165-9. doi: 10.1016/j.jinf.2013.09.028.
89. Pietruczuk M, Pietruczuk A, Pancewicz S, Zajkowska J, Swierzbińska R, Hermanowska-Szpakowicz T. Intercellular adhesion molecules sICAM-1, sICAM-2, sICAM-3 and IFNgamma in neuroborreliosis and tick-borne encephalitis. Przegl Epidemiol. 2006;60 Suppl 1:109-17. [Article in Polish]
90. Zajkowska J, Moniuszko-Malinowska A, Pancewicz SA, Muszyńska-Mazur A, Kondrusik M, Grygorczuk S, Swierzbińska-Pijanowska R, Dunaj J, Czupryna P. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE). Adv Med Sci. 2011;56(2):311-7. doi: 10.2478/v10039-011-0033-z.
91. Blom K, Braun M, Pakalniene J, Lunemann S, Enqvist M, Dailidyte L, Schaffer M, Lindquist L, Mickiene A, Michaëlsson J, Ljunggren HG, Gredmark-Russ S. NK cell responses to human tick-borne encephalitis virus infection. J Immunol. 2016;197(7):2762-71. doi: 10.4049/jimmunol.1600950.
92. Merzeniuk ZA, Lykova OF, Konysheva TV. Lactoferrin and its role in the pathogenesis of tick-borne encephalitis. Klin Lab Diagn. 2003;4:18-9. [Article in Russian]
93. Kułakowska A, Zajkowska JM, Ciccarelli NJ, Mroczko B, Drozdowski W, Bucki R. Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis. Neurodegener Dis. 2011;8(5):375-80. doi: 10.1159/000324373.
94. Moniuszko A, Pancewicz S, Czupryna P, Grygorczuk S, Świerzbińska R, Kondrusik M, Penza P, Zajkowska J. ssICAM-1, IL-21 and IL-23 in patients with tick borne encephalitis and neuroborreliosis. Cytokine. 2012;60(2):468-72. doi: 10.1016/j.cyto.2012.05.007.
95. Blom K, Braun M, Pakalniene J, Dailidyte L, Béziat V, Lampen MH, Klingström J, Lagerqvist N, Kjerstadius T, Michaëlsson J, Lindquist L, Ljunggren HG, Sandberg JK, Mickiene A, Gredmark-Russ S. Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection. PLoS Pathog. 2015;11(1):e1004622. doi: 10.1371/journal.ppat.1004622.
96. Gomez I, Marx F, Saurwein-Teissl M, Gould EA, Grubeck-Loebenstein B. Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus. Viral Immunol. 2003;16(3):407-14.
97. Aberle JH, Schwaiger J, Aberle SW, Stiasny K, Scheinost O, Kundi M, Chmelik V, Heinz FX. Human CD4+ T helper cell responses after tick-borne encephalitis vaccination and infection. PLoS One. 2015;10(10):e0140545. doi: 10.1371/journal.pone.0140545.